glucosamine has been researched along with Glycogen Storage Disease Type II in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creutzfeldt, W; Lamberts, R; Lembcke, B; Wöhler, J | 1 |
1 other study(ies) available for glucosamine and Glycogen Storage Disease Type II
Article | Year |
---|---|
Lysosomal storage of glycogen as a sequel of alpha-glucosidase inhibition by the absorbed deoxynojirimycin derivative emiglitate (BAYo1248). A drug-induced pattern of hepatic glycogen storage mimicking Pompe's disease (glycogenosis type II).
Topics: 1-Deoxynojirimycin; Acarbose; Animals; Female; Glucosamine; Glycogen Storage Disease Type II; Glycoside Hydrolase Inhibitors; Imino Pyranoses; Liver; Liver Glycogen; Lysosomes; Microscopy, Electron; Rats; Rats, Inbred Strains; Trisaccharides | 1991 |